SPECTRUM PHARMACEUTICALS INC·4

Dec 18, 7:18 PM ET

Turgeon Joseph W. 4

4 · SPECTRUM PHARMACEUTICALS INC · Filed Dec 18, 2020

Insider Transaction Report

Form 4
Period: 2020-12-16
Turgeon Joseph W.
Chief Commercial Officer
Transactions
  • Sale

    Common Stock, $0.001 par value

    2020-12-16$4.70/sh150,899$709,225377,762 total
Holdings
  • Common Stock, $0.001 par value

    (indirect: By 401(k))
    1,538
Footnotes (2)
  • [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax obligations.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.62 to $4.95, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION